No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.
www.meribank.com.twNo one on the platform currently holds 4724.TWO.
No tracked institution reports a position in 4724.TWO as of their last filing.
No one on the platform has traded 4724.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4724.TWOMeribank Biotech Co., Ltd | $8.87 | -0.67% | $851M | — |
| 1762.TWChunghwa Chemical Synthesis & Biotech Co., Ltd. | $33.65 | +0.45% | $2.6B | — |
| 3164.TWGenMont Biotech Incorporation | $15.85 | +0.96% | $1.4B | — |
| 4133.TWAbnova (Taiwan) Corporation | $20.20 | +0.00% | $1.2B | — |
| 4171.TWOGeneReach Biotechnology Corp. | $16.30 | +0.93% | $934M | — |
| 4195.TWOGenomics BioSci & Tech. Co.,Ltd. | $29.45 | +0.00% | $2.4B | — |
| 6564.TWOEnimmune corporation | $16.80 | +8.04% | $1.2B | — |
Source: Financial Modeling Prep · peers by sector/industry